PVP Ventures Limited has informed the Exchange about the completion of first phrase of acquisition of stake in 7Med India Private Limited ("7Med").
PVP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
PVP Ventures has completed the first phase of its acquisition of a stake in 7Med India Private Limited, a top-five player in India's dialysis services sector. With this completion, PVP now holds 14,939 equity shares, representing 33.24% of 7Med's paid-up share capital, with a binding agreement to scale up to 50.62% within twelve months. The total outlay for the full majority stake is approximately INR 127 crores, funded through a cash consideration combining primary and secondary share purchases. 7Med reported an EBITDA of around INR 10 crore for the current financial year. The deal is a pure diversification move into healthcare, as 7Med's business is outside PVP's main line, and it is not a related-party transaction.
This is a strategic diversification into the healthcare/dialysis segment and may be viewed positively by investors, though the phased acquisition and ~INR 127 crore cash outlay over 12 months could keep stock action range-bound until further milestones are met.